Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christoph R Meier

Showing results (1-10 of 189) with videos related to

Pageof 19
Sort By:
Therapeutische Umschau. Revue Therapeutique|June 10, 2011
[Health risks of oral contraceptives]Christoph R Meier
International Journal of Epidemiology|October 21, 2006
Commentary: statins and fracture risk--unresolved questionsChristoph R Meier
Expert Opinion on Drug Safety|April 16, 2009
Statins and the risk of Parkinson disease: an update on the controversyClaudia Becker, Christoph R Meier
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|January 20, 2004
Effect of selective serotonin reuptake inhibitors on platelet activation: can they prevent acute myocardial infarction?Raymond G Schlienger, Christoph R Meier
Drugs & Aging|April 17, 2003
HMG-CoA reductase inhibitors in osteoporosis: do they reduce the risk of fracture?Raymond G Schlienger, Christoph R Meier
Drug Safety|February 11, 2017
Antenatal Exposure and Diseases in the Offspring: The Role of Big DataChristoph R Meier, Susan S Jick
Pharmacotherapy|March 20, 2002
Association between acetaminophen or nonsteroidal antiinflammatory drugs and risk of developing ovarian, breast, or colon cancerChristoph R Meier, Stephen Schmitz, Hershel Jick
Drug Safety|February 6, 2004
The risk of severe depression, psychosis or panic attacks with prophylactic antimalarialsChristoph R Meier, Karen Wilcock, Susan S Jick
Ophthalmology|June 3, 2017
Selective Serotonin Reuptake Inhibitors and Cataract Risk: A Case-Control AnalysisClaudia Becker, Susan S Jick, Christoph R Meier
Diabetes Care|May 25, 2013
Comment on: Suissa and Azoulay. Metformin and the risk of cancer: time-related biases in observational studies. Diabetes Care 2012;35:2665-2673Michael Bodmer, Susan S Jick, Christoph R Meier
Pageof 19

Showing results (1-10 of 189) with videos related to

Sort By:
Pageof 19
Therapeutische Umschau. Revue Therapeutique|June 10, 2011
[Health risks of oral contraceptives]Christoph R Meier
International Journal of Epidemiology|October 21, 2006
Commentary: statins and fracture risk--unresolved questionsChristoph R Meier
Expert Opinion on Drug Safety|April 16, 2009
Statins and the risk of Parkinson disease: an update on the controversyClaudia Becker, Christoph R Meier
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|January 20, 2004
Effect of selective serotonin reuptake inhibitors on platelet activation: can they prevent acute myocardial infarction?Raymond G Schlienger, Christoph R Meier
Drugs & Aging|April 17, 2003
HMG-CoA reductase inhibitors in osteoporosis: do they reduce the risk of fracture?Raymond G Schlienger, Christoph R Meier
Drug Safety|February 11, 2017
Antenatal Exposure and Diseases in the Offspring: The Role of Big DataChristoph R Meier, Susan S Jick
Pharmacotherapy|March 20, 2002
Association between acetaminophen or nonsteroidal antiinflammatory drugs and risk of developing ovarian, breast, or colon cancerChristoph R Meier, Stephen Schmitz, Hershel Jick
Drug Safety|February 6, 2004
The risk of severe depression, psychosis or panic attacks with prophylactic antimalarialsChristoph R Meier, Karen Wilcock, Susan S Jick
Ophthalmology|June 3, 2017
Selective Serotonin Reuptake Inhibitors and Cataract Risk: A Case-Control AnalysisClaudia Becker, Susan S Jick, Christoph R Meier
Diabetes Care|May 25, 2013
Comment on: Suissa and Azoulay. Metformin and the risk of cancer: time-related biases in observational studies. Diabetes Care 2012;35:2665-2673Michael Bodmer, Susan S Jick, Christoph R Meier
Pageof 19